Titan Pharmaceuticals (TTNP) Short Interest Ratio & Short Volume $4.62 -0.03 (-0.65%) Closing price 05/28/2025 03:59 PM EasternExtended Trading$4.62 0.00 (-0.11%) As of 05/28/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Titan Pharmaceuticals Short Interest DataTitan Pharmaceuticals (TTNP) has a short interest of 8,300 shares, representing 1.27% of the float (the number of shares available for trading by the public). This marks a -4.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 139,081 shares to cover all short positions.Current Short Interest8,300 sharesPrevious Short Interest8,700 sharesChange Vs. Previous Month-4.60%Dollar Volume Sold Short$40,338.00Short Interest Ratio0.2 Days to CoverLast Record DateMay 15, 2025Outstanding Shares914,000 sharesFloat Size651,100 sharesShort Percent of Float1.27%Today's Trading Volume16,143 sharesAverage Trading Volume139,081 sharesToday's Volume Vs. Average12% Short Selling Titan Pharmaceuticals? Sign up to receive the latest short interest report for Titan Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTTNP Short Interest Over TimeTTNP Days to Cover Over TimeTTNP Percentage of Float Shorted Over Time Titan Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20258,300 shares $40,338.00 -4.6%1.3%0.2 $4.86 4/30/20258,700 shares $32,451.00 +20.8%1.3%0.2 $3.73 4/15/20257,200 shares $26,784.00 -5.3%1.1%0.2 $3.72 3/31/20257,600 shares $26,828.00 -20.8%1.2%0.2 $3.53 3/15/20259,600 shares $35,424.00 -25.0%1.5%0.2 $3.69 2/28/202512,800 shares $50,944.00 -53.1%2.0%0.3 $3.98 2/15/202527,300 shares $110,019.00 +16.2%4.2%0.7 $4.03 1/31/202523,500 shares $76,375.00 +58.8%3.6%0.8 $3.25 1/15/202514,800 shares $48,544.00 +15.6%2.3%0.5 $3.28 12/31/202412,800 shares $41,728.00 +18.5%2.0%0.6 $3.26 Get the Latest News and Ratings for TTNP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Titan Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/202410,800 shares $38,448.00 +18.7%1.7%0.6 $3.56 11/30/20249,100 shares $34,398.00 +4.6%1.4%0.6 $3.78 11/15/20248,700 shares $33,147.00 -13.9%1.3%0.3 $3.81 10/31/202410,100 shares $40,299.00 -40.6%1.6%0 $3.99 10/15/202417,000 shares $80,070.00 -9.1%2.6%0 $4.71 9/30/202418,700 shares $98,549.00 -3.6%2.9%0 $5.27 9/15/202419,400 shares $107,476.00 +13.5%3.0%0 $5.54 8/31/202417,100 shares $104,823.00 +271.7%2.6%0 $6.13 8/15/20244,600 shares $23,092.00 +2.2%0.7%0 $5.02 7/31/20244,500 shares $26,235.00 -48.9%0.7%0.7 $5.83 7/15/20248,800 shares $40,920.00 -24.8%1.4%1.4 $4.65 6/30/202411,700 shares $65,169.00 +50.0%1.8%2.1 $5.57 6/15/20247,800 shares $54,132.00 -4.9%1.2%1.1 $6.94 5/31/20248,200 shares $53,383.64 -13.7%1.3%1.3 $6.51 5/15/20249,500 shares $60,800.00 -19.5%1.5%1.4 $6.40 4/30/202411,800 shares $79,119.00 +15.7%2.0%1.5 $6.71 4/15/202410,200 shares $74,023.44 +161.5%1.7%0.9 $7.26 3/31/20243,900 shares $27,924.00 -67.5%0.6%0.3 $7.16 3/15/202412,000 shares $112,920.00 -0.8%2.2%1.1 $9.41 2/29/202412,100 shares $90,750.00 +10.0%2.2%1.4 $7.50 2/15/202411,000 shares $74,800.00 +111.5%2.0%1.3 $6.80 1/31/20245,200 shares $29,952.00 +2.0%1.0%0.7 $5.76 1/15/20245,100 shares $32,742.00 +15.9%0.9%1.1 $6.42 12/31/20234,400 shares $36,300.00 -56.4%N/A1.2 $8.25 12/15/202310,100 shares $2,776.49 -87.3%N/A0.2 $0.27 11/30/202379,400 shares $27,790.00 -17.5%N/A2.1 $0.35 11/15/202396,200 shares $35,594.00 +3.4%N/A2.6 $0.37 10/31/202393,000 shares $37,246.50 +49.5%N/A2.5 $0.40 10/15/202362,200 shares $28,612.00 -12.4%N/A0.7 $0.46 9/30/202371,000 shares $33,654.00 -14.5%N/A0.8 $0.47Gold Hits New Highs as Global Markets Spiral (Ad)When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.Go Here to Learn What's Happening and How to Prepare >> 9/15/202383,000 shares $40,105.60 -6.3%N/A0.9 $0.48 8/31/202388,600 shares $45,451.80 -21.9%N/A1 $0.51 8/15/2023113,500 shares $61,063.00 -68.7%N/A1.3 $0.54 7/31/2023362,200 shares $222,028.60 +500.7%N/A4.3 $0.61 7/15/202360,300 shares $38,531.70 +24.3%N/A2.8 $0.64 6/30/202348,500 shares $31,340.70 -1.2%N/A2.6 $0.65 6/15/202349,100 shares $36,825.00 No ChangeN/A3.4 $0.75 5/31/202349,100 shares $37,512.40 +6.3%N/A3.5 $0.76 5/15/202346,200 shares $34,885.62 -26.1%N/A3.1 $0.76 4/30/202362,500 shares $48,731.25 +12.2%N/A4 $0.78 4/15/202355,700 shares $44,003.00 +24.1%N/A2.4 $0.79 3/31/202344,900 shares $37,267.00 +8.7%N/A1.8 $0.83 3/15/202341,300 shares $31,598.63 +4.0%N/A1.3 $0.77 2/28/202339,700 shares $37,016.28 -30.0%N/A1 $0.93 2/15/202356,700 shares $54,035.10 -28.4%N/A1.4 $0.95 1/31/202379,200 shares $80,784.00 -16.3%N/A1.9 $1.02 1/15/202394,600 shares $87,296.88 -25.6%N/A2.5 $0.92 12/30/2022127,200 shares $99,610.32 -21.0%N/A3.7 $0.78 12/15/2022161,000 shares $143,290.00 -8.3%N/A5.1 $0.89 11/30/2022175,500 shares $142,506.00 -22.5%N/A5.5 $0.81 11/15/2022226,300 shares $217,859.01 +0.7%N/A6.5 $0.96 10/31/2022224,800 shares $224,800.00 -17.2%N/A4.6 $1.00 10/15/2022271,600 shares $274,316.00 -11.2%N/A4.3 $1.01 9/30/2022306,000 shares $330,480.00 -28.5%N/A3.6 $1.08 9/15/2022427,700 shares $560,287.00 -11.7%N/A0.8 $1.31 8/31/2022484,400 shares $639,408.00 +7.2%N/A0.8 $1.32 8/15/2022452,000 shares $687,040.00 -30.1%N/A0.7 $1.52 7/31/2022646,600 shares $853,512.00 +0.8%6.7%0.9 $1.32 7/15/2022641,800 shares $782,996.00 +77.2%6.7%0.8 $1.22 6/30/2022362,300 shares $202,453.24 -9.5%3.8%0.5 $0.56 6/15/2022400,200 shares $232,116.00 +263.2%N/A1.1 $0.58 5/31/2022110,200 shares $45,865.24 -40.5%N/A0.3 $0.42 5/15/2022185,300 shares $104,935.39 -1.6%N/A0.7 $0.57 4/30/2022188,300 shares $131,245.10 -40.9%N/A1.2 $0.70 4/15/2022318,400 shares $280,096.48 +15.8%N/A1.9 $0.88 3/31/2022275,000 shares $263,037.50 +1.1%N/A2 $0.96 3/15/2022272,100 shares $265,025.40 -17.3%N/A0.8 $0.97 2/28/2022328,900 shares $335,478.00 -2.9%N/A1.1 $1.02 2/15/2022338,800 shares $399,784.00 -6.0%N/A1.1 $1.18 1/31/2022360,300 shares $378,315.00 -9.9%N/A1.2 $1.05 1/15/2022399,700 shares $403,697.00 -15.5%N/A1.1 $1.01 12/31/2021473,100 shares $482,562.00 +44.9%N/A1.2 $1.02 12/15/2021326,600 shares $369,058.00 -3.1%N/A0.9 $1.13 11/30/2021336,900 shares $485,102.31 -19.7%N/A1.8 $1.44 11/15/2021419,700 shares $679,914.00 -7.8%N/A2.2 $1.62 10/29/2021455,000 shares $782,600.00 +20.3%N/A2.5 $1.72 10/15/2021378,200 shares $673,196.00 +57.3%N/A2.1 $1.78 9/30/2021240,400 shares $449,548.00 -6.0%N/A2.9 $1.87 9/15/2021255,700 shares $526,742.00 +39.1%N/A2.7 $2.06 8/31/2021183,800 shares $411,712.00 -36.3%1.9%1.8 $2.24Is President Trump Lying To You With This? (Ad)President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.Protect your IRA—Trump’s warning was real 8/13/2021288,500 shares $628,930.00 -18.6%2.9%2.7 $2.18 7/30/2021354,200 shares $793,408.00 -12.3%3.6%3 $2.24 7/15/2021403,700 shares $924,473.00 -4.4%4.1%2.9 $2.29 6/30/2021422,400 shares $1.10 million -21.1%4.3%2.3 $2.60 6/15/2021535,400 shares $1.34 million -21.2%5.4%2.5 $2.50 5/28/2021679,500 shares $1.66 million -24.0%6.9%2.1 $2.44 5/14/2021894,200 shares $2.00 million -14.8%9.1%2 $2.24 4/30/20211,050,000 shares $2.63 million -13.2%10.7%1.1 $2.50 4/15/20211,210,000 shares $2.95 million -19.3%12.3%0.8 $2.44 3/31/20211,500,000 shares $4.28 million -2.6%15.2%0.9 $2.85 3/15/20211,540,000 shares $5.04 million -2.5%15.6%0.9 $3.27 2/26/20211,580,000 shares $5.28 million +20.6%16.0%0.9 $3.34 2/12/20211,310,000 shares $5.02 million +133.7%13.3%0.6 $3.83 1/29/2021560,500 shares $1.80 million +9.9%5.7%0.3 $3.22 1/15/2021509,900 shares $1.78 million -15.1%5.2%0.3 $3.50 12/31/2020600,600 shares $1.95 million -28.1%8.5%0.4 $3.25 12/15/2020834,700 shares $2.74 million -95.0%11.8%0.6 $3.28 11/30/202016,600,000 shares $88.20 million +61.8%N/A11.8 $5.31 11/15/202010,260,000 shares $36.17 million -30.6%N/A0.3 $3.53 10/30/202014,790,000 shares $64.34 million +133.7%N/A0.9 $4.35 10/15/20206,330,000 shares $29.28 million -1.4%N/A1.2 $4.63 9/30/20206,420,000 shares $31.86 million -5.0%N/A1.4 $4.96 9/15/20206,760,000 shares $43.60 million -3.7%N/A1 $6.45 8/31/20207,020,000 shares $48.61 million +2.2%N/A1 $6.92 8/14/20206,870,000 shares $57.71 million -1.6%N/A0.7 $8.40 7/31/20206,980,000 shares $60.94 million -5.9%N/A0.6 $8.73 7/15/20207,420,000 shares $62.33 million -3.3%N/A0.6 $8.40 6/30/20207,670,000 shares $70.46 million -8.4%N/A0.6 $9.19 6/15/20208,370,000 shares $83.26 million +7.6%N/A0.7 $9.95 5/29/20207,780,000 shares $66.12 million -5.5%N/A0.7 $8.50 TTNP Short Interest - Frequently Asked Questions What is Titan Pharmaceuticals' current short interest? Short interest is the volume of Titan Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 8,300 shares of TTNP short. 1.27% of Titan Pharmaceuticals' shares are currently sold short. Learn More on Titan Pharmaceuticals' current short interest. What is a good short interest percentage for Titan Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.27% of Titan Pharmaceuticals' floating shares are currently sold short. Is Titan Pharmaceuticals' short interest increasing or decreasing? Titan Pharmaceuticals saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 8,300 shares, a drop of 4.6% from the previous total of 8,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Titan Pharmaceuticals' float size? Titan Pharmaceuticals currently has issued a total of 914,000 shares. Some of Titan Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Titan Pharmaceuticals currently has a public float of 651,100 shares. How does Titan Pharmaceuticals' short interest compare to its competitors? 1.27% of Titan Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Titan Pharmaceuticals: Flora Growth Corp. (1.41%), VYNE Therapeutics Inc. (1.67%), GlycoMimetics, Inc. (2.85%), Cingulate Inc. (3.52%), Allarity Therapeutics, Inc. (10.75%), GeoVax Labs, Inc. (8.73%), Leap Therapeutics, Inc. (6.15%), Cocrystal Pharma, Inc. (0.09%), Equillium, Inc. (0.66%), MEI Pharma, Inc. (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Titan Pharmaceuticals stock? Short selling TTNP is an investing strategy that aims to generate trading profit from Titan Pharmaceuticals as its price is falling. TTNP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Titan Pharmaceuticals? A short squeeze for Titan Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TTNP, which in turn drives the price of the stock up even further. How often is Titan Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TTNP, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Flora Growth Short Interest VYNE Therapeutics Short Interest GlycoMimetics Short Interest Cingulate Short Interest Allarity Therapeutics Short Interest GeoVax Labs Short Interest Leap Therapeutics Short Interest Cocrystal Pharma Short Interest Equillium Short Interest MEI Pharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TTNP) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TTNP Stock Free TTNP Stock Alerts